NYSE:AET - Aetna Stock Price, Price Target & More

$177.10 +0.18 (+0.10 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$177.10
Today's Range$176.18 - $177.42
52-Week Range$132.16 - $194.40
Volume2.28 million shs
Average Volume2.50 million shs
Market Capitalization$57.84 billion
P/E Ratio17.96
Dividend Yield1.13%
Beta0.67

About Aetna (NYSE:AET)

Aetna logoAetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.

Receive AET News and Ratings via Email

Sign-up to receive the latest news and ratings for AET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:AET
CUSIP00817Y10
Phone860-273-0123

Debt

Debt-to-Equity Ratio0.52%
Current Ratio0.65%
Quick Ratio0.65%

Price-To-Earnings

Trailing P/E Ratio17.96
Forward P/E Ratio16.07
P/E Growth1.43

Sales & Book Value

Annual Sales$60.54 billion
Price / Sales0.96
Cash Flow$12.4543 per share
Price / Cash14.22
Book Value$48.46 per share
Price / Book3.65

Profitability

EPS (Most Recent Fiscal Year)$9.86
Net Income$1.90 billion
Net Margins3.15%
Return on Equity21.50%
Return on Assets5.87%

Miscellaneous

Employees47,950
Outstanding Shares326,940,000

How to Become a New Pot Stock Millionaire

Aetna (NYSE:AET) Frequently Asked Questions

What is Aetna's stock symbol?

Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."

How often does Aetna pay dividends? What is the dividend yield for Aetna?

Aetna declared a quarterly dividend on Friday, February 23rd. Investors of record on Thursday, April 12th will be paid a dividend of $0.50 per share on Friday, April 27th. This represents a $2.00 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Wednesday, April 11th. View Aetna's Dividend History.

How will Aetna's stock buyback program work?

Aetna declared that its Board of Directors has initiated a stock buyback program on Friday, April 7th 2017, which authorizes the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 98% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its shares are undervalued.

How were Aetna's earnings last quarter?

Aetna (NYSE:AET) issued its quarterly earnings data on Tuesday, January, 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.18 by $0.07. The business had revenue of $14.74 billion for the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a net margin of 3.15% and a return on equity of 21.50%. Aetna's revenue for the quarter was down 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.08 EPS. View Aetna's Earnings History.

When is Aetna's next earnings date?

Aetna is scheduled to release their next quarterly earnings announcement on Tuesday, May, 1st 2018. View Earnings Estimates for Aetna.

What price target have analysts set for AET?

18 brokerages have issued 12 month target prices for Aetna's shares. Their forecasts range from $158.00 to $212.00. On average, they expect Aetna's share price to reach $189.8235 in the next year. View Analyst Ratings for Aetna.

What are Wall Street analysts saying about Aetna stock?

Here are some recent quotes from research analysts about Aetna stock:
  • 1. According to Zacks Investment Research, "Aetna’s third-quarter earnings surpassed the Zacks Consensus Estimate and grew year over year, driven by strong underwriting margin performance, disciplined pricing, a focus on high quality care management, and a decline in medical cost. Aetna’s shares have outperformed the industry year to date. We expect the company to witness long-term growth from its Government business and International expansion. Its cost-reduction initiatives will aid margins. The sale of its Group Life and Disability business will help it to focus on core growth areas. Following strong third-quarter results, Aetna raised its earnings guidance, cementing investors' confidence in it. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (11/2/2017)
  • 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
  • 3. Royal Bank of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)

Who are some of Aetna's key competitors?

Who are Aetna's key executives?

Aetna's management team includes the folowing people:
  • Mr. Mark Thomas Bertolini, Chairman & CEO (Age 61)
  • Ms. Karen Sue Lynch, Pres (Age 55)
  • Mr. Shawn Michael Guertin, Exec. VP, CFO & Chief Enterprise Risk Officer (Age 54)
  • Mr. Thomas J. Sabatino Jr., Exec. VP & Gen. Counsel (Age 59)
  • Ms. Margaret M. McCarthy, Exec. VP of Operations & Technology (Age 64)

Has Aetna been receiving favorable news coverage?

Headlines about AET stock have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Aetna earned a coverage optimism score of 0.12 on Accern's scale. They also assigned media headlines about the company an impact score of 45.99 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Aetna?

Shares of AET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aetna's stock price today?

One share of AET stock can currently be purchased for approximately $177.10.

How big of a company is Aetna?

Aetna has a market capitalization of $57.84 billion and generates $60.54 billion in revenue each year. The company earns $1.90 billion in net income (profit) each year or $9.86 on an earnings per share basis. Aetna employs 47,950 workers across the globe.

How can I contact Aetna?

Aetna's mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company can be reached via phone at 860-273-0123 or via email at [email protected]


MarketBeat Community Rating for Aetna (AET)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  708 (Vote Outperform)
Underperform Votes:  481 (Vote Underperform)
Total Votes:  1,189
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe AET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AET will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aetna (NYSE:AET) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
18 Wall Street analysts have issued ratings and price targets for Aetna in the last 12 months. Their average twelve-month price target is $189.8235, suggesting that the stock has a possible upside of 7.18%. The high price target for AET is $212.00 and the low price target for AET is $158.00. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.612.652.642.65
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $189.8235$189.8235$177.5556$163.4706
Price Target Upside: 7.18% upside1.27% upside5.45% downside0.60% upside

Aetna (NYSE:AET) Consensus Price Target History

Price Target History for Aetna (NYSE:AET)

Aetna (NYSE:AET) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/31/2018Jefferies GroupReiterated RatingHold$205.00LowView Rating Details
1/31/2018Credit Suisse GroupBoost Price TargetNeutral -> Neutral$200.00 -> $208.00MediumView Rating Details
1/31/2018CitigroupDowngradeBuy -> Neutral$187.89 -> $212.00LowView Rating Details
1/30/2018CowenReiterated RatingBuy$212.00LowView Rating Details
1/30/2018Piper JaffrayReiterated RatingBuy$212.00LowView Rating Details
1/22/2018Deutsche BankUpgradeHold -> Buy$195.00 -> $212.00LowView Rating Details
12/20/2017Morgan StanleyDowngradeOverweight -> Equal Weight$179.00LowView Rating Details
12/6/2017ArgusDowngradeBuy -> Hold$185.00LowView Rating Details
12/4/2017Wells FargoReiterated RatingOutperform$200.00 -> $208.00HighView Rating Details
11/3/2017Raymond JamesUpgradeMarket Perform -> Outperform$200.00N/AView Rating Details
10/27/2017BMO Capital MarketsBoost Price TargetMarket Perform$175.00 -> $200.00N/AView Rating Details
10/26/2017Cantor FitzgeraldDowngradeOverweight -> NeutralN/AView Rating Details
8/4/2017Royal Bank of CanadaBoost Price TargetOutperform -> Outperform$162.00 -> $171.00MediumView Rating Details
5/17/2017UBSReiterated RatingBuy$147.00 -> $160.00N/AView Rating Details
5/17/2017Bank of AmericaReiterated RatingBuy$160.00 -> $168.00MediumView Rating Details
5/16/2017Stifel NicolausBoost Price TargetBuy -> Buy$150.00 -> $158.00LowView Rating Details
5/15/2017BarclaysReiterated RatingOverweight$162.00LowView Rating Details
5/11/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
4/3/2017CIBCReiterated RatingOutperformLowView Rating Details
3/31/2017OppenheimerReiterated RatingOutperformLowView Rating Details
1/31/2017Sanford C. BernsteinDowngradeOutperform -> Market PerformN/AView Rating Details
1/24/2017Leerink SwannDowngradeOutperform -> Market Perform$135.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/AView Rating Details
8/17/2016FBR & CoReiterated RatingHoldN/AView Rating Details
7/21/2016Wolfe ResearchDowngradeOutperform -> Peer PerformN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Aetna (NYSE:AET) Earnings History and Estimates Chart

Earnings by Quarter for Aetna (NYSE:AET)

Aetna (NYSE:AET) Earnings Estimates

2018 EPS Consensus Estimate: $11.08
2019 EPS Consensus Estimate: $12.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$2.95$3.18$3.05
Q2 20183$3.31$3.47$3.37
Q3 20183$2.75$3.07$2.93
Q4 20183$1.57$1.95$1.73
Q1 20191$3.45$3.45$3.45
Q2 20191$3.62$3.62$3.62
Q3 20191$3.26$3.26$3.26
Q4 20191$2.17$2.17$2.17

Aetna (NYSE AET) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2018$2.98N/AView Earnings Details
1/30/2018Q4 2017$1.18$1.25$14.7884 billion$14.7420 billionViewN/AView Earnings Details
10/31/2017Q3 2017$2.06$2.45$15.1197 billion$14.9940 billionViewN/AView Earnings Details
8/3/2017Q2 2017$2.34$3.42$15.3354 billion$15.5230 billionViewListenView Earnings Details
5/2/2017Q1 2017$2.36$2.71$15.3893 billion$15.1650 billionViewListenView Earnings Details
1/31/2017Q416$1.44$1.63$15.84 billion$15.73 billionViewListenView Earnings Details
10/27/2016Q316$2.02$2.07$15.71 billion$15.78 billionViewListenView Earnings Details
8/2/2016Q216$2.12$2.21$15.69 billion$15.95 billionViewListenView Earnings Details
4/28/2016Q116$2.23$2.30$15.46 billion$15.69 billionViewListenView Earnings Details
2/1/2016Q415$1.21$1.37$14.93 billion$15.09 billionViewListenView Earnings Details
10/29/2015Q315$1.77$1.90$15.22 billion$15.00 billionViewListenView Earnings Details
8/4/2015Q215$1.82$2.05$15.43 billion$15.13 billionViewListenView Earnings Details
4/28/2015Q115$1.96$2.39$15.48 billion$15.09 billionViewListenView Earnings Details
2/3/2015Q414$1.22$1.22$14.59 million$14.77 millionViewListenView Earnings Details
10/28/2014Q214$1.58$1.79$14.63 billion$14.70 billionViewListenView Earnings Details
7/29/2014Q114$1.61$1.69$13.98 billion$14.50 billionViewListenView Earnings Details
4/24/2014Q413$1.56$1.98$13.69 billion$13.97 billionViewListenView Earnings Details
2/6/2014Q313$1.36$1.34$13.14 billion$13.13 billionViewListenView Earnings Details
10/29/2013Q213$1.53$1.53$12.89 billion$12.99 billionViewListenView Earnings Details
7/30/2013Q2 2013$1.39$1.52$12.02 billion$11.56 billionViewListenView Earnings Details
4/30/2013Q1 2013$1.38$1.50$9.65 billion$9.51 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.96$0.94$8.97 billion$8.96 billionViewListenView Earnings Details
10/25/2012Q312$1.34$1.55$8.96 billion$8.90 billionViewN/AView Earnings Details
7/31/2012$1.25$1.31ViewN/AView Earnings Details
4/26/2012$1.39$1.34ViewN/AView Earnings Details
2/1/2012$0.96$0.97ViewN/AView Earnings Details
10/27/2011$1.14$1.40ViewN/AView Earnings Details
7/27/2011$1.07$1.35ViewN/AView Earnings Details
4/28/2011$0.97$1.43ViewN/AView Earnings Details
2/4/2011$0.62$0.63ViewN/AView Earnings Details
11/3/2010Q3 2010$0.67$0.84ViewN/AView Earnings Details
7/27/2010Q2 2010$0.73$1.05ViewN/AView Earnings Details
4/29/2010Q1 2010$0.72$0.77ViewN/AView Earnings Details
2/5/2010Q4 2009$0.42$0.40ViewN/AView Earnings Details
10/29/2009Q3 2009$0.66$0.69ViewN/AView Earnings Details
7/27/2009Q2 2009$0.79$0.69ViewN/AView Earnings Details
4/29/2009Q1 2009$0.93$0.96ViewN/AView Earnings Details
2/12/2009Q4 2008$0.95$0.96ViewN/AView Earnings Details
10/29/2008Q3 2008$1.12$1.12ViewN/AView Earnings Details
7/31/2008Q2 2008$0.93$0.94ViewN/AView Earnings Details
4/24/2008Q1 2008$0.92$0.92ViewN/AView Earnings Details
2/7/2008Q4 2007$0.88$0.88ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Aetna (NYSE:AET) Dividend Information

Aetna pays an annual dividend of $2.00 per share, with a dividend yield of 1.13%. AET's next quarterly dividend payment will be made on Friday, April 27. Aetna pays out 20.28% of its earnings out as a dividend.
Next Dividend:4/27/2018
Annual Dividend:$2.00
Dividend Yield:1.13%
Dividend Growth:24.80% (3 Year Average)
Payout Ratio:20.28% (Trailing 12 Months of Earnings)
18.15% (Based on This Year's Estimates)
16.34% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Aetna (NYSE:AET)

Aetna (NYSE:AET) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/23/2018quarterly$0.501.13726828158763%4/11/20184/12/20184/27/2018
12/4/2017quarterly$0.501.12%1/10/20181/11/20181/26/2018
9/29/2017quarterly$0.501.25%10/11/201710/12/201710/27/2017
5/19/2017quarterly$0.501.42%7/11/20177/13/20177/28/2017
2/17/2017quarterly$0.501.58%4/11/20174/13/20174/28/2017
12/2/2016quarterly$0.250.77%1/10/20171/12/20171/27/2017
9/30/2016quarterly$0.250.87%10/11/201610/13/201610/28/2016
5/20/2016quarterly$0.250.91%7/12/20167/14/20167/29/2016
2/19/2016quarterly$0.250.94%4/12/20164/14/20164/29/2016
12/4/2015quarterly$0.250.97%1/12/20161/14/20161/29/2016
9/25/2015quarterly$0.250.95%10/13/201510/15/201510/30/2015
5/15/2015quarterly$0.250.88%7/14/20157/16/20157/31/2015
2/27/2015quarterly$0.251%4/7/20154/9/20154/24/2015
11/21/2014quarterly$0.251.15%1/13/20151/15/20151/30/2015
9/19/2014quarterly$0.22501.08%10/14/201410/16/201410/31/2014
5/30/2014quarterly$0.22501.16%7/8/20147/10/20147/25/2014
2/28/2014quarterly$0.22501.25%4/8/20144/10/20144/25/2014
12/6/2013quarterly$0.22501.35%1/14/20141/16/20141/31/2014
9/27/2013quarterly$0.201.25%10/8/201310/10/201310/25/2013
5/17/2013quarterly$0.201.35%7/9/20136/11/20137/26/2013
2/19/2013quarterly$0.201.66%4/9/20134/11/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Aetna (NYSE AET) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.21%
Institutional Ownership Percentage: 87.22%
Insider Trading History for Aetna (NYSE:AET)
Institutional Ownership by Quarter for Aetna (NYSE:AET)

Aetna (NYSE AET) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/18/2017Karen S LynchPresidentSell15,271$161.91$2,472,527.6164,261View SEC Filing  
9/15/2017Margaret M MccarthyEVPSell10,288$162.85$1,675,400.8033,563View SEC Filing  
6/7/2017Margaret M MccarthyEVPSell27,028$149.23$4,033,388.4433,563View SEC Filing  
5/17/2017Mark T BertoliniChairmanSell103,547$140.79$14,578,382.13659,888View SEC Filing  
3/23/2017Shawn M GuertinInsiderSell29,602$129.35$3,829,018.7044,880View SEC Filing  
3/8/2017Francis S Soistman JrVPSell6,607$131.98$871,991.8623,454View SEC Filing  
9/7/2016Jeffrey E. GartenDirectorSell7,100$116.51$827,221.00View SEC Filing  
8/23/2016Shawn M GuertinInsiderSell45,328$120.21$5,448,878.8844,883View SEC Filing  
5/10/2016Margaret M MccarthyEVPSell39,169$114.45$4,482,892.0556,240View SEC Filing  
5/3/2016Mark T BertoliniCEOSell33,510$114.00$3,820,140.00496,588View SEC Filing  
3/15/2016Gary W LovemanEVPBuy8,970$111.45$999,706.509,605View SEC Filing  
2/22/2016Molly Joel CoyeDirectorSell1,175$106.28$124,879.008,104View SEC Filing  
12/23/2015Margaret M MccarthyEVPSell18,373$109.97$2,020,478.8163,515View SEC Filing  
12/22/2015Mark T. BertoliniCEOSell26,996$110.00$2,969,560.00729,194View SEC Filing  
8/14/2015Joseph M ZubretskyEVPSell179,087$118.66$21,250,463.42View SEC Filing  
8/13/2015Franklin Barbara HackmanDirectorSell2,064$118.47$244,522.08View SEC Filing  
3/31/2015Joseph M ZubretskyEVPSell200,000$107.96$21,592,000.00View SEC Filing  
3/27/2015Joseph M ZubretskyEVPSell86,958$107.24$9,325,375.92View SEC Filing  
3/26/2015Joseph M ZubretskyInsiderSell162,066$106.98$17,337,820.68View SEC Filing  
3/26/2015Margaret M MccarthyEVPSell27,670$106.04$2,934,126.80View SEC Filing  
3/25/2015Franklin Barbara HackmanDirectorSell3,000$108.75$326,250.00View SEC Filing  
3/17/2015William James CasazzaVPSell14,000$105.07$1,470,980.00View SEC Filing  
3/2/2015Molly Joel CoyeDirectorSell2,500$100.27$250,675.00View SEC Filing  
2/10/2015Rajan ParmeswarVPSell5,300$95.60$506,680.00View SEC Filing  
6/16/2014Molly Joel CoyeDirectorSell1,650$80.60$132,990.00View SEC Filing  
6/12/2014William James CasazzaVPSell15,906$80.58$1,281,705.48View SEC Filing  
5/27/2014Franklin Barbara HackmanDirectorSell2,665$77.26$205,897.90View SEC Filing  
2/19/2014Rajan ParmeswarVPSell3,600$69.46$250,056.003,829View SEC Filing  
12/30/2013Mark BertoliniCEOSell130,272$68.08$8,868,917.76526,938View SEC Filing  
12/27/2013William James CasazzaVPSell10,299$68.25$702,906.7533,903View SEC Filing  
8/26/2013William James CasazzaVPSell15,745$64.66$1,018,071.7033,903View SEC Filing  
6/18/2013William James CasazzaVPSell40,598$62.00$2,517,076.00View SEC Filing  
5/21/2013Molly Joel CoyeDirectorSell2,000$60.38$120,760.00View SEC Filing  
5/20/2013Joseph P NewhouseDirectorSell14,000$59.15$828,100.00View SEC Filing  
5/15/2013Rajan ParmeswarVPSell1,435$60.13$86,286.55View SEC Filing  
2/6/2013Karen RohanVPBuy4,035$49.53$199,853.55View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Aetna (NYSE AET) News Headlines

Source:
DateHeadline
UnitedHealth Group Posted Strong 1Q18 PerformanceUnitedHealth Group Posted Strong 1Q18 Performance
finance.yahoo.com - April 23 at 5:24 PM
Better Buy: CVS Health Corporation vs. Express ScriptsBetter Buy: CVS Health Corporation vs. Express Scripts
finance.yahoo.com - April 22 at 8:01 AM
What Are The Next Big Dividend Stocks?What Are The Next Big Dividend Stocks?
finance.yahoo.com - April 18 at 5:28 PM
BRIEF-Aetna To Release Q1 2018 Results; Announces Business Segment RealignmentBRIEF-Aetna To Release Q1 2018 Results; Announces Business Segment Realignment
www.reuters.com - April 17 at 5:40 PM
Aetna to Release First-Quarter 2018 Results; Announces Business Segment RealignmentAetna to Release First-Quarter 2018 Results; Announces Business Segment Realignment
finance.yahoo.com - April 17 at 5:39 PM
Heres What to Watch as UnitedHealth Reports Earnings on TuesdayHere's What to Watch as UnitedHealth Reports Earnings on Tuesday
finance.yahoo.com - April 16 at 5:38 PM
Analysts’ Recommendations for UnitedHealth GroupAnalysts’ Recommendations for UnitedHealth Group
finance.yahoo.com - April 16 at 9:09 AM
Aetna to Post Q1 2018 Earnings of $3.01 Per Share, Jefferies Group Forecasts (AET)Aetna to Post Q1 2018 Earnings of $3.01 Per Share, Jefferies Group Forecasts (AET)
www.americanbankingnews.com - April 16 at 1:50 AM
Aetna (AET) Downgraded by BidaskClub to HoldAetna (AET) Downgraded by BidaskClub to Hold
www.americanbankingnews.com - April 15 at 12:36 AM
Prescription drug costs: Insurers look to pass price breaks straight to the consumerPrescription drug costs: Insurers look to pass price breaks straight to the consumer
www.usatoday.com - April 14 at 5:35 PM
Aetna Inc (AET) Forecasted to Earn Q3 2018 Earnings of $3.07 Per ShareAetna Inc (AET) Forecasted to Earn Q3 2018 Earnings of $3.07 Per Share
www.americanbankingnews.com - April 13 at 8:55 AM
$15.20 Billion in Sales Expected for Aetna Inc (AET) This Quarter$15.20 Billion in Sales Expected for Aetna Inc (AET) This Quarter
www.americanbankingnews.com - April 13 at 4:04 AM
Shady Grove Fertility Atlanta Invited into Aetnas Institute of Excellence ™ Infertility NetworkShady Grove Fertility Atlanta Invited into Aetna's Institute of Excellence ™ Infertility Network
www.benzinga.com - April 12 at 5:35 PM
Aetna (AET) Stock Rating Reaffirmed by Cantor FitzgeraldAetna (AET) Stock Rating Reaffirmed by Cantor Fitzgerald
www.americanbankingnews.com - April 12 at 2:19 PM
Stock Traders Buy Large Volume of Aetna Put Options (AET)Stock Traders Buy Large Volume of Aetna Put Options (AET)
www.americanbankingnews.com - April 12 at 7:01 AM
Aetna Inc (AET) Expected to Post Earnings of $3.01 Per ShareAetna Inc (AET) Expected to Post Earnings of $3.01 Per Share
www.americanbankingnews.com - April 11 at 9:19 AM
Aetna Inc. (AET) Ex-Dividend Date Scheduled for April 11, 2018Aetna Inc. (AET) Ex-Dividend Date Scheduled for April 11, 2018
www.nasdaq.com - April 10 at 5:31 PM
Aetna About To Put More Money In Your Pocket (AET)Aetna About To Put More Money In Your Pocket (AET)
www.nasdaq.com - April 9 at 5:35 PM
Aetna (AET) Rating Lowered to Hold at Zacks Investment ResearchAetna (AET) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 8 at 10:51 AM
Aetna (AET) Downgraded to Hold at Zacks Investment ResearchAetna (AET) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - April 7 at 9:13 AM
BRIEF-Aetna Says Chairman And CEO Mark Bertolinis FY 2017 Total Compensation Was $18.8 MlnBRIEF-Aetna Says Chairman And CEO Mark Bertolini's FY 2017 Total Compensation Was $18.8 Mln
www.reuters.com - April 6 at 5:33 PM
Blue Cross Blue Shield Insurers may be afoul of antitrust lawBlue Cross Blue Shield Insurers may be afoul of antitrust law
seekingalpha.com - April 6 at 5:33 PM
Aetna (AET) Downgraded by Zacks Investment Research to "Hold"Aetna (AET) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - April 5 at 7:58 PM
Aetna (AET) Stock Rating Lowered by Cantor FitzgeraldAetna (AET) Stock Rating Lowered by Cantor Fitzgerald
www.americanbankingnews.com - April 4 at 6:22 PM
Are Options Traders Betting on a Big Move in Aetna (AET) Stock?Are Options Traders Betting on a Big Move in Aetna (AET) Stock?
finance.yahoo.com - April 3 at 5:30 PM
Aetna and Harvard T.H. Chan School of Public Health Launch Five-Year Well-Being Research InitiativeAetna and Harvard T.H. Chan School of Public Health Launch Five-Year Well-Being Research Initiative
finance.yahoo.com - April 3 at 5:30 PM
Are Options Traders Betting on a Big Move in Aetna (AET) Stock? April 03, 2018Are Options Traders Betting on a Big Move in Aetna (AET) Stock? April 03, 2018
www.zacks.com - April 3 at 8:12 AM
Aetna (AET) PT Raised to $185.00 at Jefferies GroupAetna (AET) PT Raised to $185.00 at Jefferies Group
www.americanbankingnews.com - April 2 at 12:26 PM
Citigroup Increases Aetna (AET) Price Target to $197.00Citigroup Increases Aetna (AET) Price Target to $197.00
www.americanbankingnews.com - April 2 at 12:30 AM
Aetna Inc (AET) Receives Consensus Rating of "Buy" from AnalystsAetna Inc (AET) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 1 at 1:36 AM
Aetna (AET) Rating Increased to Buy at ValuEngineAetna (AET) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - March 31 at 3:48 PM
Aetna (AET) Rating Increased to Overweight at Piper JaffrayAetna (AET) Rating Increased to Overweight at Piper Jaffray
www.americanbankingnews.com - March 31 at 12:12 AM
M&A News: Walmart in Talks to Buy Health Insurer HumanaM&A News: Walmart in Talks to Buy Health Insurer Humana
finance.yahoo.com - March 30 at 5:36 PM
Walmart in early talks to buy insurer Humana, report saysWalmart in early talks to buy insurer Humana, report says
www.usatoday.com - March 30 at 8:27 AM
Aetna Drug Rehab Resource Developed From Heroin Detox ClinicsAetna Drug Rehab Resource Developed From Heroin Detox Clinics
globenewswire.com - March 30 at 8:27 AM
Aetna will pass drug rebates along to portion of membersAetna will pass drug rebates along to portion of members
www.marketwatch.com - March 28 at 8:00 AM
CEO named to lead Allina-Aetnas health-insurance joint ventureCEO named to lead Allina-Aetna's health-insurance joint venture
www.bizjournals.com - March 27 at 5:32 PM
Aetna Will Pass Along Discounts as Drug Price Scrutiny IncreasesAetna Will Pass Along Discounts as Drug Price Scrutiny Increases
www.bloomberg.com - March 27 at 5:32 PM
Tom Lindquist Tapped as CEO of Allina Health Aetna Joint VentureTom Lindquist Tapped as CEO of Allina Health Aetna Joint Venture
finance.yahoo.com - March 27 at 5:32 PM
CEO named to lead Allina-Aetna's health-insurance joint ventureCEO named to lead Allina-Aetna's health-insurance joint venture
finance.yahoo.com - March 27 at 5:32 PM
Aetna will pass drug discounts along to some members at the pharmacy counterAetna will pass drug discounts along to some members at the pharmacy counter
finance.yahoo.com - March 27 at 5:32 PM
Aetna (AET) Upgraded to Buy at Deutsche BankAetna (AET) Upgraded to Buy at Deutsche Bank
www.americanbankingnews.com - March 27 at 10:26 AM
Aetna to pass on drug rebates to some its membersAetna to pass on drug rebates to some its members
www.cnbc.com - March 27 at 9:30 AM
 Brokerages Anticipate Aetna Inc (AET) Will Post Quarterly Sales of $15.20 Billion Brokerages Anticipate Aetna Inc (AET) Will Post Quarterly Sales of $15.20 Billion
www.americanbankingnews.com - March 27 at 4:59 AM
Piper Jaffray Reiterates Buy Rating for Aetna (AET)Piper Jaffray Reiterates Buy Rating for Aetna (AET)
www.americanbankingnews.com - March 26 at 1:26 PM
Cowen Reaffirms Buy Rating for Aetna (AET)Cowen Reaffirms Buy Rating for Aetna (AET)
www.americanbankingnews.com - March 26 at 1:26 PM
Aetna (AET) Rating Lowered to Neutral at CitigroupAetna (AET) Rating Lowered to Neutral at Citigroup
www.americanbankingnews.com - March 26 at 11:38 AM
Why Aetna Inc Stock Will Rebound SoonWhy Aetna Inc Stock Will Rebound Soon
investorplace.com - March 26 at 10:30 AM
Aetna Rankings On Healthy CommunitiesAetna Rankings On Healthy Communities
www.msn.com - March 26 at 8:59 AM
U.S. News and Aetna Foundation Release Inaugural Healthiest Communities RankingsU.S. News and Aetna Foundation Release Inaugural Healthiest Communities Rankings
www.prnewswire.com - March 26 at 1:54 AM

SEC Filings

Aetna (NYSE:AET) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Aetna (NYSE:AET) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Aetna (NYSE AET) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.